Scott Gottlieb, commissioner of the Food and Drug Administration, told The Washington Post this week that his agency will require…
Home » Medications »
CymaBay Therapeutics Announces Seladelpar Granted Breakthrough Therapy Designation by the FDA for the Treatment of Primary Biliary Cholangitis
NEWARK, Calif., Feb. 15, 2019 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), today announced that the U.S. Food and…
FDA Approves Keytruda (pembrolizumab) for the Adjuvant Treatment of Patients with Melanoma with Involvement of Lymph Node(s) Following Complete Resection
KENILWORTH, N.J.–(BUSINESS WIRE) February 19, 2019 –Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced…
What’s the Best Treatment for Bacterial Vaginosis?
Luckily, BV is easily treated with simple antibiotics. In some women, the infection comes back, and they have to take…
FDA Approves Jeuveau
NEWPORT BEACH, Calif., Feb. 01, 2019 (GLOBE NEWSWIRE) — Evolus, Inc. (NASDAQ: EOLS) today announced that the U.S. Food and…
On its own, Trump admin’s price disclosure policy unlikely to help curb drug prices
The Trump administration’s proposal to require pharmaceutical companies to publish drug prices in TV ads is unlikely to help control…
New study shows physician-targeted marketing is associated with increase in opioid overdose deaths
Many individuals cite prescription opioids as their gateway to illicit opioid use. However, while prescription opioids are involved in more…
Researchers see possible link between opioids, birth defect
Health officials are looking into a possible link between prescription opioids and a horrific birth defect. When a baby is…
Viriom to Report Results from Phase 1b Clinical Trial of Once Weekly Oral HIV Treatment
SAN DIEGO, Dec. 21, 2018 /PRNewswire/ — Viriom (San Diego, CA) announced today that it plans to report results from…